|
1
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lai HW, Wei JC, Hung HC and Lin CC: Tumor
sidedness influences prognostic impact of lymph node metastasis in
colon cancer patients undergoing curative surgery. Sci Rep.
9:198922019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh RK and Lokeshwar BL: The
IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling
to promote prostate cancer growth. Cancer Res. 71:3268–3277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xue TC, Han D, Chen RX, Zou JH, Wang Y,
Tang ZY and Ye SL: High expression of CXCR7 combined with alpha
fetoprotein in hepatocellular carcinoma correlates with
extra-hepatic metastasis to lung after hepatectomy. Asian Pac J
Cancer Prev. 12:657–663. 2011.PubMed/NCBI
|
|
7
|
Li XX, Zheng HT, Huang LY, Shi DB, Peng
JJ, Liang L and Cai SJ: Silencing of CXCR7 gene represses growth
and invasion and induces apoptosis in colorectal cancer through ERK
and β-arrestin pathways. Int J Oncol. 45:1649–1657. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miao Z, Luker KE, Summers BC, Berahovich
R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A,
Luker GD, et al: CXCR7 (RDC1) promotes breast and lung tumor growth
in vivo and is expressed on tumor-associated vasculature. Proc Natl
Acad Sci USA. 104:15735–15740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Floranović MP and Veličković LJ: Effect of
CXCL12 and its receptors on unpredictable renal cell carcinoma.
Clin Genitourin Cancer. Dec 4–2019.(Epub ahead of print).
View Article : Google Scholar
|
|
10
|
Atanes P, Hawkes RG, Olaniru OE,
Ruz-Maldonado I, Amisten S and Persaud SJ: CXCL14 inhibits insulin
secretion independently of CXCR4 or CXCR7 receptor activation or
cAMP inhibition. Cell Physiol Biochem. 52:879–892. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang H, Wang P, Zhang X, Zhao W, Ren H
and Hu Z: SDF1/CXCR7 signaling axis participates in angiogenesis in
degenerated discs via the PI3K/AKT pathway. DNA Cell Biol.
38:457–467. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balabanian K, Lagane B, Infantino S, Chow
KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M and
Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals
through the orphan receptor RDC1 in T lymphocytes. J Biol Chem.
280:35760–35766. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Daniel SK, Seo YD and Pillarisetty VG: The
CXCL12- CXCR4/CXCR7 axis as a mechanism of immune resistance in
gastrointestinal malignancies. Semin Cancer Biol. Dec 23–2019.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Shiozawa Y, Wang J, Wang Y, Jung
Y, Pienta KJ, Mehra R, Loberg R and Taichman RS: The role of
CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate
cancer. J Biol Chem. 283:4283–4294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liberman J, Sartelet H, Flahaut M,
Mühlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM and
Gross N: Involvement of the CXCR7/CXCR4/CXCL12 axis in the
malignant progression of human neuroblastoma. PLoS One.
7:e436652012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stacer AC, Fenner J, Cavnar SP, Xiao A,
Zhao S, Chang SL, Salomonnson A, Luker KE and Luker GD: Endothelial
CXCR7 regulates breast cancer metastasis. Oncogene. 35:1716–1724.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HX, Tao LY, Qi KE, Zhang HY, Feng D,
Wei WJ, Kong H, Chen TW, Lin QS and Chen DJ: Role of CXC chemokine
receptor type 7 in carcinogenesis and lymph node metastasis of
colon cancer. Mol Clin Oncol. 3:1229–1232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hao M, Zheng J, Hou K and Wang J, Chen X,
Lu X, Bo J, Xu C, Shen K and Wang J: Role of chemokine receptor
CXCR7 in bladder cancer progression. Biochem Pharmacol. 84:204–214.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heinrich EL, Lee W, Lu J, Lowy AM and Kim
J: Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated
signaling pathways in pancreatic cancer cells. J Transl Med.
10:682012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tachezy M, Zander H, Gebauer F, von Loga
K, Pantel K, Izbicki JR and Bockhorn M: CXCR7 expression in
esophageal cancer. J Transl Med. 11:2382013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Yang L, Teng X, Zhang H and Guan H:
The involvement of CXCR7 in modulating the progression of papillary
thyroid carcinoma. J Surg Res. 191:379–388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wani N, Nasser MW, Ahirwar DK, Zhao H,
Miao Z, Shilo K and Ganju RK: C-X-C motif chemokine 12/C-X-C
chemokine receptor type 7 signaling regulates breast cancer growth
and metastasis by modulating the tumor microenvironment. Breast
Cancer Res. 16:R542014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao ZW, Fan XX, Song JJ, Xu M, Chen MJ,
Tu JF, Wu FZ, Zhang DK, Liu L, Chen L, et al: ShRNA knock-down of
CXCR7 inhibits tumour invasion and metastasis in hepatocellular
carcinoma after transcatheter arterial chemoembolization. J Cell
Mol Med. 21:1989–1999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Wang X, Li Z, Zhang Z and Zhang Y:
Chemokine receptor 7 targets the vascular endothelial growth factor
via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
Cancer Med. 8:5327–5340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ben-Baruch A: Organ selectivity in
metastasis: Regulation by chemokines and their receptors. Clin Exp
Metastasis. 25:345–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Romain B, Hachet-Haas M, Rohr S, Brigand
C, Galzi JL, Gaub MP, Pencreach E and Guenot D: Hypoxia
differentially regulated CXCR4 and CXCR7 signaling in colon cancer.
Mol Cancer. 13:582014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu Y, Li H, Xue B, Jiang X, Huang K, Ge J,
Zhang H and Chen B: SDF-1/CXCR7 axis enhances ovarian cancer cell
invasion by MMP-9 expression through p38 MAPK pathway. DNA Cell
Biol. 33:543–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qian T, Liu Y, Dong Y, Zhang L, Dong Y,
Sun Y and Sun D: CXCR7 regulates breast tumor metastasis and
angiogenesis in vivo and in vitro. Mol Med Rep.
17:3633–3639. 2018.PubMed/NCBI
|
|
32
|
Kollmar O, Rupertus K, Scheuer C, Nickels
RM, Haberl GC, Tilton B, Menger MD and Schilling MK: CXCR4 and
CXCR7 regulate angiogenesis and CT26.WT tumor growth independent
from SDF-1. Int J Cancer. 126:1302–1315. 2010.PubMed/NCBI
|
|
33
|
Yang D, Dai T, Xue L, Liu X, Wu B, Geng J,
Mao X, Wang R, Chen L and Chu X: Expression of chemokine receptor
CXCR7 in colorectal carcinoma and its prognostic significance. Int
J Clin Exp Pathol. 8:13051–13058. 2015.PubMed/NCBI
|
|
34
|
Guillemot E, Karimdjee-Soilihi B, Pradelli
E, Benchetrit M, Goguet-Surmenian E, Millet MA, Larbret F, Michiels
JF, Birnbaum D, Alemanno P, et al: CXCR7 receptors facilitate the
progression of colon carcinoma within lung not within liver. Br J
Cancer. 107:1944–1949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Tao L, Qi KE, Zhang H, Feng D, Wei
W, Kong H, Chen T, Lin Q and Chen D: CXCR7 functions in colon
cancer cell survival and migration. Exp Ther Med. 10:1720–1724.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Xu P, Qiu L, Zhang M, Huang Y and
Zheng JC: CXCR7 participates in CXCL12-mediated cell cycle and
proliferation regulation in mouse neural progenitor cells. Curr Mol
Med. 16:738–746. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim HY, Lee SY, Kim DY, Moon JY, Choi YS,
Song IC, Lee HJ, Yun HJ, Kim S and Jo DY: Expression and functional
roles of the chemokine receptor CXCR7 in acute myeloid leukemia
cells. Blood Res. 50:218–226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin L, Han MM, Wang F, Xu LL, Yu HX and
Yang PY: CXCR7 stimulates MAPK signaling to regulate hepatocellular
carcinoma progression. Cell Death Dis. 5:e14882014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gebauer F, Tachezy M, Effenberger K, von
Loga K, Zander H, Marx A, Kaifi JT, Sauter G, Izbicki JR and
Bockhorn M: Prognostic impact of CXCR4 and CXCR7 expression in
pancreatic adenocarcinoma. J Surg Oncol. 104:140–145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
